BR100 Increased By (0.84%)
BR30 Increased By (0.71%)
KSE100 Increased By (0.68%)
KSE30 Increased By (0.7%)
AGHA 7.76 Increased By ▲ 0.01 (0.13%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 57.60 Decreased By ▼ -1.06 (-1.81%)
BOP 34.28 Increased By ▲ 0.59 (1.75%)
CNERGY 10.95 Increased By ▲ 0.34 (3.2%)
CSIL 5.48 Increased By ▲ 0.18 (3.4%)
FCCL 54.51 Increased By ▲ 0.77 (1.43%)
FFL 16.66 Increased By ▲ 0.20 (1.22%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.39 Increased By ▲ 0.11 (1.51%)
KOSM 5.79 Increased By ▲ 0.15 (2.66%)
LOTCHEM 29.83 Increased By ▲ 0.18 (0.61%)
MLCF 95.90 Decreased By ▼ -0.46 (-0.48%)
NBP 204.99 Increased By ▲ 1.46 (0.72%)
NCPL 57.89 Increased By ▲ 1.04 (1.83%)
NPL 69.70 Increased By ▲ 2.39 (3.55%)
OGDC 318.50 Increased By ▲ 0.28 (0.09%)
PACE 10.90 Increased By ▲ 0.27 (2.54%)
PAEL 43.00 Increased By ▲ 1.23 (2.94%)
PIBTL 16.90 Increased By ▲ 0.09 (0.54%)
PPL 221.50 Increased By ▲ 1.33 (0.6%)
PRL 52.30 Increased By ▲ 3.25 (6.63%)
PTC 71.30 Increased By ▲ 1.29 (1.84%)
SSGC 29.35 Increased By ▲ 0.21 (0.72%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.93 Increased By ▲ 0.11 (1.25%)
TPL 17.85 Increased By ▲ 0.68 (3.96%)
TPLP 12.92 Increased By ▲ 0.41 (3.28%)
TREET 22.83 Increased By ▲ 0.24 (1.06%)
TRG 59.95 Decreased By ▼ -0.27 (-0.45%)
By

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed for this article.